124 related articles for article (PubMed ID: 37997910)
1. Association between sociodemographic and clinical features, health behaviors, and health literacy of patients with prostate cancer and prostate cancer prognostic stage.
Braga R; Araújo N; Costa A; Lopes C; Silva I; Correia R; Carneiro F; Braga I; Pacheco-Figueiredo L; Oliveira J; Morais S; Tedim Cruz V; Pereira S; Lunet N
Eur J Cancer Prev; 2024 May; 33(3):243-251. PubMed ID: 37997910
[TBL] [Abstract][Full Text] [Related]
2. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.
Ratti MM; Gandaglia G; Alleva E; Leardini L; Sisca ES; Derevianko A; Furnari F; Mazzoleni Ferracini S; Beyer K; Moss C; Pellegrino F; Sorce G; Barletta F; Scuderi S; Omar MI; MacLennan S; Williamson PR; Zong J; MacLennan SJ; Mottet N; Cornford P; Aiyegbusi OL; Van Hemelrijck M; N'Dow J; Briganti A;
Eur Urol Oncol; 2022 Apr; 5(2):153-163. PubMed ID: 34785188
[TBL] [Abstract][Full Text] [Related]
3. Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality of life in prostate cancer survivors: a curate's egg.
O'Leary E; Drummond FJ; Gavin A; Kinnear H; Sharp L
Qual Life Res; 2015 Sep; 24(9):2219-30. PubMed ID: 25791618
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Cohort profile: the Martinique Cancer Registry and the quality of life prostate cancer cohort (QoL Prostate-MQ): challenges and prospects for reducing disparities in the Caribbean.
Joachim C; Veronique-Baudin J; Almont T; Ulric-Gervaise S; Macni J; Pierre-Louis O; Godaert L; Drame M; Novella JL; Farid K; Vinh-Hung V; Escarmant P
BMJ Open; 2018 Jul; 8(7):e021540. PubMed ID: 30049695
[TBL] [Abstract][Full Text] [Related]
6. High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy?
Mahal BA; Chen MH; Bennett CL; Kattan MW; Sartor O; Stein K; D'Amico AV; Nguyen PL
Ann Oncol; 2015 Jul; 26(7):1390-5. PubMed ID: 25926039
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
8. Effect of investigation intensity and treatment differences on prostate cancer survivor's physical symptoms, psychological well-being and health-related quality of life: a two country cross-sectional study.
Gavin AT; Donnelly D; Donnelly C; Drummond FJ; Morgan E; Gormley GJ; Sharp L
BMJ Open; 2016 Dec; 6(12):e012952. PubMed ID: 27993906
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial.
Tombal B; Saad F; Penson D; Hussain M; Sternberg CN; Morlock R; Ramaswamy K; Ivanescu C; Attard G
Lancet Oncol; 2019 Apr; 20(4):556-569. PubMed ID: 30770294
[TBL] [Abstract][Full Text] [Related]
10. Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer.
Bennett CL; Ferreira MR; Davis TC; Kaplan J; Weinberger M; Kuzel T; Seday MA; Sartor O
J Clin Oncol; 1998 Sep; 16(9):3101-4. PubMed ID: 9738581
[TBL] [Abstract][Full Text] [Related]
11. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
Preston MA; Gerke T; Carlsson SV; Signorello L; Sjoberg DD; Markt SC; Kibel AS; Trinh QD; Steinwandel M; Blot W; Vickers AJ; Lilja H; Mucci LA; Wilson KM
Eur Urol; 2019 Mar; 75(3):399-407. PubMed ID: 30237027
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Quality of Life Subjective Perception by Patients Treated for Prostate Cancer with the EORTC QLQ-C30 Questionnaire and QLQ-PR25 Module.
Dąbrowska-Bender M; Słoniewski R; Religioni U; Juszczyk G; Słoniewska A; Staniszewska A
J Cancer Educ; 2017 Sep; 32(3):509-515. PubMed ID: 26614256
[TBL] [Abstract][Full Text] [Related]
13. [What do prostate cancer patients know about smoking? : Results of a bicentric questionnaire study (KRAUT study)].
May M; Gilfrich C; Spachmann P; Maurer O; Dombrowski MK; Fritsche HM; Wöhr M; Brookman-May S; Karl T; Schostak M; Burger M; Lebentrau S
Urologe A; 2016 Aug; 55(8):1078-85. PubMed ID: 27364819
[TBL] [Abstract][Full Text] [Related]
14. How does health literacy affect quality of life among men with newly diagnosed clinically localized prostate cancer? Findings from the North Carolina-Louisiana Prostate Cancer Project (PCaP).
Song L; Mishel M; Bensen JT; Chen RC; Knafl GJ; Blackard B; Farnan L; Fontham E; Su LJ; Brennan CS; Mohler JL; Godley PA
Cancer; 2012 Aug; 118(15):3842-51. PubMed ID: 22180041
[TBL] [Abstract][Full Text] [Related]
15. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
Klein EA; Cooperberg MR; Magi-Galluzzi C; Simko JP; Falzarano SM; Maddala T; Chan JM; Li J; Cowan JE; Tsiatis AC; Cherbavaz DB; Pelham RJ; Tenggara-Hunter I; Baehner FL; Knezevic D; Febbo PG; Shak S; Kattan MW; Lee M; Carroll PR
Eur Urol; 2014 Sep; 66(3):550-60. PubMed ID: 24836057
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in long-term Caribbean prostate cancer survivors: comparisons with prostate cancer-free men.
Jackson MD; Walker E; Tulloch-Reid MK
Qual Life Res; 2022 Dec; 31(12):3391-3401. PubMed ID: 35900615
[TBL] [Abstract][Full Text] [Related]
17. The Europa Uomo Patient Reported Outcome Study 2.0-Prostate Cancer Patient-reported Outcomes to Support Treatment Decision-making.
Venderbos LDF; Remmers S; Deschamps A; Dowling J; Carl EG; Pereira-Azevedo N; Roobol MJ
Eur Urol Focus; 2023 Nov; 9(6):1024-1036. PubMed ID: 37268512
[TBL] [Abstract][Full Text] [Related]
18. Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series.
Buergy D; Schneiberg V; Schaefer J; Welzel G; Trojan L; Bolenz C; Wenz F
Health Qual Life Outcomes; 2018 Jan; 16(1):21. PubMed ID: 29357874
[TBL] [Abstract][Full Text] [Related]
19. Patient Characteristics at Prostate Cancer Diagnosis in Different Races at an Academic Center Serving a Diverse Population.
Suresh T; Sharma J; Goel S; Kovac E; Gao Q; Gartrell B
Clin Genitourin Cancer; 2019 Apr; 17(2):139-144. PubMed ID: 30655076
[TBL] [Abstract][Full Text] [Related]
20. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25.
Park J; Shin DW; Yun SJ; Park SW; Jeon SS; Kwak C; Kwon TG; Kim HJ; Ahn H
Oncology; 2013; 85(5):299-305. PubMed ID: 24217330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
